Arbutus Biopharma (ABUS) Other Non Operating Income: 2009-2025
Historic Other Non Operating Income for Arbutus Biopharma (ABUS) over the last 16 years, with Sep 2025 value amounting to -$12,000.
- Arbutus Biopharma's Other Non Operating Income fell 340.00% to -$12,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$20,000, marking a year-over-year decrease of 900.00%. This contributed to the annual value of -$49,000 for FY2024, which is 296.00% down from last year.
- Latest data reveals that Arbutus Biopharma reported Other Non Operating Income of -$12,000 as of Q3 2025, which was down 157.14% from $21,000 recorded in Q2 2025.
- Arbutus Biopharma's Other Non Operating Income's 5-year high stood at $28,000 during Q1 2021, with a 5-year trough of -$33,000 in Q4 2024.
- Its 3-year average for Other Non Operating Income is -$1,000, with a median of $4,000 in 2025.
- As far as peak fluctuations go, Arbutus Biopharma's Other Non Operating Income spiked by 450.00% in 2023, and later crashed by 900.00% in 2024.
- Quarterly analysis of 5 years shows Arbutus Biopharma's Other Non Operating Income stood at $5,000 in 2021, then plummeted by 180.00% to -$4,000 in 2022, then soared by 450.00% to $14,000 in 2023, then plummeted by 335.71% to -$33,000 in 2024, then crashed by 340.00% to -$12,000 in 2025.
- Its Other Non Operating Income was -$12,000 in Q3 2025, compared to $21,000 in Q2 2025 and $4,000 in Q1 2025.